GEN Exclusives

More »

GEN Poll

More »
Nov 26, 2012

Female Sexual Dysfunction Drugs

While men have had Viagra, Cialis, and Levitra to address their sexual dysfunction issues for about a decade, finding a solution for women’s woes has been more complicated. The market for female sexual dysfunction (FSD) drugs is believed larger than the market for male sexual dysfunction treatments, yet despite this no FDA-approved treatments for FSD exist—though several drug developers are closer than ever to changing that. Once approved, how much of a rise do you think they’ll get in sales compared to ED drugs?

Do you think future FSD drugs have the potential to be as successful as ED drugs have been?


More Polls » View Results »

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

GEN Poll

More » Poll Results »

Moral Calculations May Shift Biobank Balances

How should consent terms reconcile donors’ moral concerns with biobanks’ research goals?